Porcine islet amyloid polypeptide fragments are refractory to amyloid formation

FEBS Letters

Volumn 585, Issue 1, 2011, Pages 71-77

  Zhang, Xin ^a   Cheng, Biao ^a   Gong, Hao ^a   Li, Chuanzhou ^b   Chen, Hong ^a   Zheng, Ling ^b   Huang, Kun ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b WUHAN UNIVERSITY   (China)

Author keywords

Amylin; Amyloid fibril; IAPP; Oligomerization; Seeding; Type 2 diabetes mellitus

Indexed keywords

AMYLIN; AMYLOID; GLYCINE; LYSINE; PEPTIDE FRAGMENT;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; HUMAN; NONHUMAN; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN SECONDARY STRUCTURE; SWINE;

AMINO ACID SUBSTITUTION; AMYLOID; ANIMALS; CELL LINE, TUMOR; CELL SURVIVAL; CHROMATOGRAPHY, GEL; CIRCULAR DICHROISM; HUMANS; ISLET AMYLOID POLYPEPTIDE; MICROSCOPY, ELECTRON, TRANSMISSION; PEPTIDE FRAGMENTS; PROTEIN MULTIMERIZATION; SWINE;

SUS;

EID: 78650908339     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2010.11.050     Document Type: Article

References (40)

1. A. Clark, S.B. Charge, M.K. Badman, D.A. MacArthur, and E.J. de Koning Islet amyloid polypeptide: actions and role in the pathogenesis of diabetes Biochem. Soc. Trans. 24 1996 594 599
2. K.H. Johnson, T.D. O'Brien, C. Betsholtz, and P. Westermark Islet amyloid, islet-amyloid polypeptide, and diabetes mellitus New Engl. J. Med. 321 1989 513 518
3. P. Westermark, U. Engstrom, K.H. Johnson, G.T. Westermark, and C. Betsholtz Islet amyloid polypeptide: pinpointing amino acid residues linked to amyloid fibril formation Proc. Natl. Acad. Sci. USA 87 1990 5036 5040
4. K.J. Potter Islet amyloid deposition limits the viability of human islet grafts but not porcine islet grafts Proc. Natl. Acad. Sci. USA 107 2010 4305 4310
5. K.H. Johnson, T.D. O'Brien, C. Betsholtz, and P. Westermark Islet amyloid polypeptide: mechanisms of amyloidogenesis in the pancreatic islets and potential roles in diabetes mellitus Lab. Invest. 66 1992 522 535
6. L.A. Scrocchi, Y. Chen, S. Waschuk, F. Wang, S. Cheung, A.A. Darabie, J. McLaurin, and P.E. Fraser Design of peptide-based inhibitors of human islet amyloid polypeptide fibrillogenesis J. Mol. Biol. 318 2002 697 706
7. A. Abedini, and D.P. Raleigh Destabilization of human IAPP amyloid fibrils by proline mutations outside of the putative amyloidogenic domain: is there a critical amyloidogenic domain in human IAPP? J. Mol. Biol. 355 2006 274 281
8. K. Huang The A-chain of insulin contacts the insert domain of the insulin receptor. Photo-cross-linking and mutagenesis of a diabetes-related crevice J. Biol. Chem. 282 2007 35337 35349
9. K. Huang, N.C. Maiti, N.B. Phillips, P.R. Carey, and M.A. Weiss Structure-specific effects of protein topology on cross-beta assembly: studies of insulin fibrillation Biochemistry 45 2006 10278 10293
10. N. Sreerama, and R.W. Woody Estimation of protein secondary structure from circular dichroism spectra: comparison of CONTIN, SELCON, and CDSSTR methods with an expanded reference set Anal. Biochem. 287 2000 252 260
11. K. Huang, J. Dong, N.B. Phillips, P.R. Carey, and M.A. Weiss Proinsulin is refractory to protein fibrillation: topological protection of a precursor protein from cross-beta assembly J. Biol. Chem. 280 2005 42345 42355
12. T. Konno, S. Oiki, and T. Morii Synergistic action of polyanionic and non-polar cofactors in fibrillation of human islet amyloid polypeptide FEBS Lett. 581 2007 1635 1638
13. C. Cabaleiro-Lago, I. Lynch, K.A. Dawson, and S. Linse Inhibition of IAPP and IAPP(20-29) fibrillation by polymeric nanoparticles Langmuir 26 2010 3453 3461
14. O. Conchillo-Sole, N.S. de Groot, F.X. Aviles, J. Vendrell, X. Daura, and S. Ventura AGGRESCAN: a server for the prediction and evaluation of "hot spots" of aggregation in polypeptides BMC Bioinform. 8 2007 65
15. T.P. Hettmansperger, and J.W. McKean Robust Nonparametric Statistical Methods 1998 John Wiley & Sons, Inc. NJ
16. R. Kayed, J. Bernhagen, N. Greenfield, K. Sweimeh, H. Brunner, W. Voelter, and A. Kapurniotu Conformational transitions of islet amyloid polypeptide (IAPP) in amyloid formation in vitro J. Mol. Biol. 287 1999 781 796
17. A. Abedini, and D.P. Raleigh The role of His-18 in amyloid formation by human islet amyloid polypeptide Biochemistry 44 2005 16284 16291
18. G. Pappalardo, D. Milardi, A. Magri, F. Attanasio, G. Impellizzeri, C. La Rosa, D. Grasso, and E. Rizzarelli Environmental factors differently affect human and rat IAPP: conformational preferences and membrane interactions of IAPP17-29 peptide derivatives Chemistry 13 2007 10204 10215
19. J. Madine, E. Jack, P.G. Stockley, S.E. Radford, L.C. Serpell, and D.A. Middleton Structural insights into the polymorphism of amyloid-like fibrils formed by region 20-29 of amylin revealed by solid-state NMR and X-ray fiber diffraction J. Am. Chem. Soc. 130 2008 14990 15001
20. K. Tenidis Identification of a penta- and hexapeptide of islet amyloid polypeptide (IAPP) with amyloidogenic and cytotoxic properties J. Mol. Biol. 295 2000 1055 1071
21. K. Jordan, M.P. Murtaugh, T.D. O'Brien, P. Westermark, C. Betsholtz, and K.H. Johnson Canine IAPP cDNA sequence provides important clues regarding diabetogenesis and amyloidogenesis in type 2 diabetes Biochem. Biophys. Res. Commun. 169 1990 502 508
22. T.D. O'Brien, P. Westermark, and K.H. Johnson Islet amyloid polypeptide (IAPP) does not inhibit glucose-stimulated insulin secretion from isolated perfused rat pancreas Biochem. Biophys. Res. Commun. 170 1990 1223 1228
23. J. Green, C. Goldsbury, T. Mini, S. Sunderji, P. Frey, J. Kistler, G. Cooper, and U. Aebi Full-length rat amylin forms fibrils following substitution of single residues from human amylin J. Mol. Biol. 326 2003 1147 1156
24. S. Sakagashira, T. Sanke, T. Hanabusa, H. Shimomura, S. Ohagi, K.Y. Kumagaye, K. Nakajima, and K. Nanjo Missense mutation of amylin gene (S20G) in Japanese NIDDM patients Diabetes 45 1996 1279 1281
25. S.C. Lee, Y. Hashim, J.K. Li, G.T. Ko, J.A. Critchley, C.S. Cockram, and J.C. Chan The islet amyloid polypeptide (amylin) gene S20G mutation in Chinese subjects: evidence for associations with type 2 diabetes and cholesterol levels Clin. Endocrinol. (Oxf.) 54 2001 541 546
26. K. Yamada, X. Yuan, S. Ishiyama, and K. Nonaka Glucose tolerance in Japanese subjects with S20G mutation of the amylin gene Diabetologia 41 1998 125
27. S. Sakagashira, H.J. Hiddinga, K. Tateishi, T. Sanke, T. Hanabusa, K. Nanjo, and N.L. Eberhardt S20G mutant amylin exhibits increased in vitro amyloidogenicity and increased intracellular cytotoxicity compared to wild-type amylin Am. J. Pathol. 157 2000 2101 2109
28. Z. Ma Enhanced in vitro production of amyloid-like fibrils from mutant (S20G) islet amyloid polypeptide Amyloid 8 2001 242 249
29. D. Zanuy, and R. Nussinov The sequence dependence of fiber organization. A comparative molecular dynamics study of the islet amyloid polypeptide segments 22-27 and 22-29 J. Mol. Biol. 329 2003 565 584
30. Y. Mo, Y. Lu, G. Wei, and P. Derreumaux Structural diversity of the soluble trimers of the human amylin(20-29) peptide revealed by molecular dynamics simulations J. Chem. Phys. 130 2009 125101
31. E. Rivera, J. Straub, and D. Thirumalai Sequence and crowding effects in the aggregation of a 10-residue fragment derived from islet amyloid polypeptide Biophys. J. 96 2009 4552 4560
32. P. Cao, F. Meng, A. Abedini, and D.P. Raleigh The ability of rodent islet amyloid polypeptide to inhibit amyloid formation by human islet amyloid polypeptide has important implications for the mechanism of amyloid formation and the design of inhibitors Biochemistry 49 2010 872 881
33. S. Luca, W.M. Yau, R. Leapman, and R. Tycko Peptide conformation and supramolecular organization in amylin fibrils: constraints from solid-state NMR Biochemistry 46 2007 13505 13522
34. N.F. Dupuis, C. Wu, J.E. Shea, and M.T. Bowers Human islet amyloid polypeptide monomers form ordered beta-hairpins: a possible direct amyloidogenic precursor J. Am. Chem. Soc. 131 2009 18283 18292
35. R.C. Elgersma, G.E. Mulder, J.A. Kruijtzer, G. Posthuma, D.T. Rijkers, and R.M. Liskamp Transformation of the amyloidogenic peptide amylin(20-29) into its corresponding peptoid and retropeptoid: access to both an amyloid inhibitor and template for self-assembled supramolecular tapes Bioorg. Med. Chem. Lett. 17 2007 1837 1842
36. J.T. Nielsen Unique identification of supramolecular structures in amyloid fibrils by solid-state NMR spectroscopy Angew. Chem., Int. Ed. Engl. 48 2009 2118 2121
37. J.J. Wiltzius, S.A. Sievers, M.R. Sawaya, D. Cascio, D. Popov, C. Riekel, and D. Eisenberg Atomic structure of the cross-beta spine of islet amyloid polypeptide (amylin) Protein Sci. 17 2008 1467 1474
38. M.R. Sawaya Atomic structures of amyloid cross-beta spines reveal varied steric zippers Nature 447 2007 453 457
39. K.J. Potter Amyloid inhibitors enhance survival of cultured human islets Biochim. Biophys. Acta 1790 2009 566 574
40. D.F. Moriarty, and D.P. Raleigh Effects of sequential proline substitutions on amyloid formation by human amylin20-29 Biochemistry 38 1999 1811 1818